ROP
53
2
IPG
50
2
LB
45
15
RSG
62
2
NSC
53
6
WDC
44
3
NDAQ
56
3
PHM
60
6
CNP
44
5
IVZ
52
6
WBA
53
5
AN
47
3
RRC
50
4
LMT
29
2
EMN
49
3
C
54
4
CINF
40
5
AVGO
32
7
UNP
48
6
MLM
58
-2
ROP
53
2
IPG
50
2
LB
45
15
RSG
62
2
NSC
53
6
WDC
44
3
NDAQ
56
3
PHM
60
6
CNP
44
5
IVZ
52
6
WBA
53
5
AN
47
3
RRC
50
4
LMT
29
2
EMN
49
3
C
54
4
CINF
40
5
AVGO
32
7
UNP
48
6
MLM
58
-2
Financhill
Back

WAVE Life Sciences 10K Form

Buy
76

WVE
WAVE Life Sciences

Last Price:
13.89
Seasonality Move:
-7.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-09 10Q WVE/WAVE Life Sciences Quarterly
2023-08-03 10Q WVE/WAVE Life Sciences Quarterly
2023-05-03 10Q WVE/WAVE Life Sciences Quarterly
2022-11-10 10Q WVE/WAVE Life Sciences Quarterly
2022-08-11 10Q WVE/WAVE Life Sciences Quarterly
2022-05-12 10Q WVE/WAVE Life Sciences Quarterly

Receive WVE News And Ratings

See the #1 stock for the next 7 days that we like better than WVE

WVE Financial Statistics

Sales & Book Value

Annual Sales: $113.31M
Cash Flow: $-27.52M
Price / Cash Flow: 0
Annual Sales: $-0.03
Price / Book: 0

Profitability

EPS (TTM): -0.57000
Net Income (TTM): $-73.49M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: -31.98%

WAVE Life Sciences Earnings Forecast

Key WAVE Life Sciences Financial Ratios

  • The Selling, General & Administrative Expenses for WVE have been equal to 45.27% of Gross Profit Margin.
  • The Research & Development expenses have been 114.74% of Revenue.
  • The Net Earning history of WVE is -50.76% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 4 years.

WAVE Life Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: WVE
CUSIP: Y95308
Website: wavelifesciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.99
Quick Ratio: 0.9

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

WVE Technical Analysis vs Fundamental Analysis

Buy
76
WAVE Life Sciences (WVE) is a Buy

Is WAVE Life Sciences a Buy or a Sell?

  • WAVE Life Sciences stock is rated a Buy
    The current WAVE Life Sciences [WVE] share price is $13.84. The Score for WVE is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.